Antares Pharma, Inc. (ATRS)

EBITDA Margin

-4.89%

Quarterly · Period ending:

ATRS logo

ATRS EBITDA Margin

Latest reported-4.89%
ATRS Quarterly EBITDA Margin (-125.00% → -4.89%)
High-resolution chart · PNG

ATRS ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. EBITDA Margin — Quarterly
Period endingEBITDA Margin
-70%
-20.1301%
-66.6667%
-75%
-125%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.